A specifikus immunterápia és hazai alkalmazásá nak tapasztalatai atopiás borgyulladásban szenvedo kutyákban

3. Specifikus immunterápia a gyakorlatban (saját vizsgálatok)

Translated title of the contribution: Specific immunotherapy and experiences of its use in Hungary in dogs suffering from atopic dermatitis. 3. Specific immunotherapy in the practice (own studies)

Tarpataki Noémi, Bagdi Nóra, Pápa Kinga, Papp László, K. Vörös

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors summarize their own experiences on 20 patients with immunotherapy against atopic dermatitis. The efficacy of the therapy, the beginning of the effect and the need for concomitant therapy were evaluated. The results were similar to those published in the literature. The allergens were diagnosed in each case in vivo by the intradermal skin test. 70% of the owners were satisfied with the effect of the hyposensibilisation. Symptoms were reduced by a minimum of 50% in 11 cases (55%) (Figure 7). In 70% of the cases concomitant therapies were needed. The half of the patients began to react to therapy between the 3rd to 6th months of the treatment. There were two peaks of the beginning of effect: on the 6th and the 16th week 20-20% of the atopic dogs began to react, respectively (Figure 2). There was large difference between the average time of existence of the symptoms before therapy between the patients who reacted well (9.2 months) and the patients who reacted poorly (19.5 months) to the hyposensibilisation (Figure 3). That is why the early diagnosis and treatment is recommended in the immunotherapy. The four patients who have been treated for 4 years didn't show any side effect during the time of the survey.

Original languageHungarian
Pages (from-to)545-552
Number of pages8
JournalMagyar Allatorvosok Lapja
Volume126
Issue number9
Publication statusPublished - Sep 2004

Fingerprint

atopic dermatitis
Hungary
immunotherapy
Atopic Dermatitis
Immunotherapy
Dogs
therapeutics
dogs
signs and symptoms (animals and humans)
Therapeutics
skin tests
early diagnosis
allergens
Intradermal Tests
adverse effects
Skin Tests
Allergens
Early Diagnosis

ASJC Scopus subject areas

  • veterinary(all)

Cite this

A specifikus immunterápia és hazai alkalmazásá nak tapasztalatai atopiás borgyulladásban szenvedo kutyákban : 3. Specifikus immunterápia a gyakorlatban (saját vizsgálatok). / Noémi, Tarpataki; Nóra, Bagdi; Kinga, Pápa; László, Papp; Vörös, K.

In: Magyar Allatorvosok Lapja, Vol. 126, No. 9, 09.2004, p. 545-552.

Research output: Contribution to journalArticle

@article{bc9b9a5a197944ed97e58dc267583cf6,
title = "A specifikus immunter{\'a}pia {\'e}s hazai alkalmaz{\'a}s{\'a} nak tapasztalatai atopi{\'a}s borgyullad{\'a}sban szenvedo kuty{\'a}kban: 3. Specifikus immunter{\'a}pia a gyakorlatban (saj{\'a}t vizsg{\'a}latok)",
abstract = "The authors summarize their own experiences on 20 patients with immunotherapy against atopic dermatitis. The efficacy of the therapy, the beginning of the effect and the need for concomitant therapy were evaluated. The results were similar to those published in the literature. The allergens were diagnosed in each case in vivo by the intradermal skin test. 70{\%} of the owners were satisfied with the effect of the hyposensibilisation. Symptoms were reduced by a minimum of 50{\%} in 11 cases (55{\%}) (Figure 7). In 70{\%} of the cases concomitant therapies were needed. The half of the patients began to react to therapy between the 3rd to 6th months of the treatment. There were two peaks of the beginning of effect: on the 6th and the 16th week 20-20{\%} of the atopic dogs began to react, respectively (Figure 2). There was large difference between the average time of existence of the symptoms before therapy between the patients who reacted well (9.2 months) and the patients who reacted poorly (19.5 months) to the hyposensibilisation (Figure 3). That is why the early diagnosis and treatment is recommended in the immunotherapy. The four patients who have been treated for 4 years didn't show any side effect during the time of the survey.",
author = "Tarpataki No{\'e}mi and Bagdi N{\'o}ra and P{\'a}pa Kinga and Papp L{\'a}szl{\'o} and K. V{\"o}r{\"o}s",
year = "2004",
month = "9",
language = "Hungarian",
volume = "126",
pages = "545--552",
journal = "Magyar Allatorvosok Lapja",
issn = "0025-004X",
publisher = "Magyar Mezogazdasag Ltd",
number = "9",

}

TY - JOUR

T1 - A specifikus immunterápia és hazai alkalmazásá nak tapasztalatai atopiás borgyulladásban szenvedo kutyákban

T2 - 3. Specifikus immunterápia a gyakorlatban (saját vizsgálatok)

AU - Noémi, Tarpataki

AU - Nóra, Bagdi

AU - Kinga, Pápa

AU - László, Papp

AU - Vörös, K.

PY - 2004/9

Y1 - 2004/9

N2 - The authors summarize their own experiences on 20 patients with immunotherapy against atopic dermatitis. The efficacy of the therapy, the beginning of the effect and the need for concomitant therapy were evaluated. The results were similar to those published in the literature. The allergens were diagnosed in each case in vivo by the intradermal skin test. 70% of the owners were satisfied with the effect of the hyposensibilisation. Symptoms were reduced by a minimum of 50% in 11 cases (55%) (Figure 7). In 70% of the cases concomitant therapies were needed. The half of the patients began to react to therapy between the 3rd to 6th months of the treatment. There were two peaks of the beginning of effect: on the 6th and the 16th week 20-20% of the atopic dogs began to react, respectively (Figure 2). There was large difference between the average time of existence of the symptoms before therapy between the patients who reacted well (9.2 months) and the patients who reacted poorly (19.5 months) to the hyposensibilisation (Figure 3). That is why the early diagnosis and treatment is recommended in the immunotherapy. The four patients who have been treated for 4 years didn't show any side effect during the time of the survey.

AB - The authors summarize their own experiences on 20 patients with immunotherapy against atopic dermatitis. The efficacy of the therapy, the beginning of the effect and the need for concomitant therapy were evaluated. The results were similar to those published in the literature. The allergens were diagnosed in each case in vivo by the intradermal skin test. 70% of the owners were satisfied with the effect of the hyposensibilisation. Symptoms were reduced by a minimum of 50% in 11 cases (55%) (Figure 7). In 70% of the cases concomitant therapies were needed. The half of the patients began to react to therapy between the 3rd to 6th months of the treatment. There were two peaks of the beginning of effect: on the 6th and the 16th week 20-20% of the atopic dogs began to react, respectively (Figure 2). There was large difference between the average time of existence of the symptoms before therapy between the patients who reacted well (9.2 months) and the patients who reacted poorly (19.5 months) to the hyposensibilisation (Figure 3). That is why the early diagnosis and treatment is recommended in the immunotherapy. The four patients who have been treated for 4 years didn't show any side effect during the time of the survey.

UR - http://www.scopus.com/inward/record.url?scp=22244470692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244470692&partnerID=8YFLogxK

M3 - Article

VL - 126

SP - 545

EP - 552

JO - Magyar Allatorvosok Lapja

JF - Magyar Allatorvosok Lapja

SN - 0025-004X

IS - 9

ER -